A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Published:2014-05-29 Issue:22 Volume:370 Page:2083-2092
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

King Talmadge E.,Bradford Williamson Z.,Castro-Bernardini Socorro,Fagan Elizabeth A.,Glaspole Ian,Glassberg Marilyn K.,Gorina Eduard,Hopkins Peter M.,Kardatzke David,Lancaster Lisa,Lederer David J.,Nathan Steven D.,Pereira Carlos A.,Sahn Steven A.,Sussman Robert,Swigris Jeffrey J.,Noble Paul W.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1402582

Cited by 3046 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of human stem cell-derived extracellular vesicles in idiopathic pulmonary fibrosis;Extracellular Vesicle;2024-12

2. “Bubbly lung”, a honeycombing variant with more favorable outcome;Respiratory Investigation;2024-11

3. A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD;Heart & Lung;2024-11

4. Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patients;World Journal of Clinical Cases;2024-10-06

5. Aerosol inhalation of total ginsenosides repairs acute lung injury and inhibits pulmonary fibrosis through SMAD2 signaling-mediated mechanism;Phytomedicine;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP